Search

Gustavo Menjivar Rodriguez

from Clayton, NC
Age ~44
Get Report
Also known as:
Gustavo A Rodriguez, Gustavo M Rodriguez, Gustavo Adolfo Menjivar, Gustavo A Menjivar, Rodriguez Gustavo Menjivar, Gustavo Menjivarrodriguez, Rodriguez Menjivar, Gustavo Z
Phone and address:
70 Trillium Way, Clayton, NC 27527
Related to:
Jose L Luna, 64Jaime Benitez, 48Jose Rodriguez, 91Maria Baez, 92
Connected to:
Aaren L Rodrigues, 50Aaron F Rodrigues, 41Abbey M Rodriguez, 36Abdi Rodriguez, 80Abelardo Rodrigues, 73Abigail RodriguezAbraham RodriguezAcirema Rodriguez, 45Adael S Rodriguez, 53Adalberto Rodriguez, 70

Gustavo Rodriguez Phones & Addresses

    s
  • 70 Trillium Way, Clayton, NC 27527
  • Raleigh, NC
  • Wake Forest, NC
  • Louisburg, NC
  • Knightdale, NC

Professional Records

Medicine Doctors

Gustavo Rodriguez Photo 1

Gustavo J. Rodriguez

View page
Specialties:
Neurology
Work:
Texas Tech University Neurology
4800 Alberta Ave, El Paso, TX 79905
(915) 215-5900 (phone), (915) 215-8615 (fax)
Education:
Medical School
Univ De Santiago, Fac De Med, Santiago De Compostela, Spain
Graduated: 1996
Procedures:
Lumbar Puncture
Conditions:
Alzheimer's Disease
Bell's Palsy
Dementia
Diabetic Peripheral Neuropathy
Epilepsy
Languages:
English
Spanish
Description:
Dr. Rodriguez graduated from the Univ De Santiago, Fac De Med, Santiago De Compostela, Spain in 1996. He works in El Paso, TX and specializes in Neurology. Dr. Rodriguez is affiliated with El Paso Childrens Hospital and University Medical Center Of El Paso.
Gustavo Rodriguez Photo 2

Gustavo C. Rodriguez

View page
Specialties:
Gynecologic Oncology
Work:
Northshore University Health System
2650 Rdg Ave, Evanston, IL 60201
(847) 570-2639 (phone), (847) 733-5618 (fax)
Education:
Medical School
University of Illinois, Chicago College of Medicine
Graduated: 1985
Procedures:
Chemotherapy
Colposcopy
Destruction of Lesions on the Anus
Hysterectomy
Ovarian Surgery
Tubal Surgery
Conditions:
Abnormal Vaginal Bleeding
Breast Disorders
Cervical Cancer
Conditions of Pregnancy and Delivery
Genital HPV
Languages:
English
French
Spanish
Description:
Dr. Rodriguez graduated from the University of Illinois, Chicago College of Medicine in 1985. He works in Evanston, IL and specializes in Gynecologic Oncology. Dr. Rodriguez is affiliated with Northshore University Health System Evanston Hospital.
Gustavo Rodriguez Photo 3

Gustavo Rodriguez

View page
Specialties:
Family Medicine
Work:
The Austin Diagnostic Clinic
1401 Medical Pkwy STE C, Cedar Park, TX 78613
(512) 901-4038 (phone), (512) 485-0085 (fax)
Education:
Medical School
University of Texas Medical Branch at Galveston
Graduated: 2009
Languages:
English
Description:
Dr. Rodriguez graduated from the University of Texas Medical Branch at Galveston in 2009. He works in Cedar Park, TX and specializes in Family Medicine.
Gustavo Rodriguez Photo 4

Gustavo Rodriguez

View page

License Records

Gustavo A Rodriguez

License #:
20732 - Expired
Category:
Nursing Support
Issued Date:
Sep 14, 1992
Effective Date:
May 28, 1998
Type:
Nurse Aide

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gustavo Rodriguez
Director
Cosmos Publicidad S.A. Corporation
Gustavo Rodriguez
Laredo Shutters, LLC

Publications

Us Patents

Prevention Of Ovarian Cancer By Administration Of A Vitamin D Compound

View page
US Patent:
6407082, Jun 18, 2002
Filed:
Jan 7, 2000
Appl. No.:
09/479837
Inventors:
Gustavo C. Rodriguez - Durham NC
Regina Salas Whitaker - Hillsborough NC
Assignee:
New Life Pharmaceuticals Inc. - Chicago IL
International Classification:
A61K 3159
US Classification:
514167, 514171
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Prevention Of Ovarian Cancer By Administration Of A Vitamin D Compound

View page
US Patent:
6444658, Sep 3, 2002
Filed:
Jan 7, 2000
Appl. No.:
09/479021
Inventors:
Gustavo C. Rodriguez - Durham NC
Regina Salas Whitaker - Hillsborough NC
Assignee:
New Life Pharmaceuticals Inc. - Chicago IL
International Classification:
A61K 3159
US Classification:
514167
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Prevention Of Ovarian Cancer By Administration Of Products That Induce Transforming Growth Factor-Beta And/Or Apoptosis In The Ovarian Epithelium

View page
US Patent:
6511970, Jan 28, 2003
Filed:
Sep 28, 2000
Appl. No.:
09/672735
Inventors:
Gustavo C. Rodriguez - Durham NC
Assignee:
New Life Pharmaceuticals Inc. - Chicago IL
International Classification:
A61K 3156
US Classification:
514179, 514170, 514178, 514181
Abstract:
The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of increasing TGF- expression in the ovarian epithelium. HRT and OCP regimens comprising such compositions and methods are disclosed.

Prevention Of Ovarian Cancer By Administration Of Progestin Products

View page
US Patent:
6977250, Dec 20, 2005
Filed:
Sep 17, 2001
Appl. No.:
09/954082
Inventors:
Gustavo C. Rodriguez - Durham NC, US
Assignee:
New Life Pharmaceuticals Inc. - Chicago IL
International Classification:
A01N045/00
A61K031/56
US Classification:
514171, 514170, 514177, 514179, 514841, 514843, 514874
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.

Prevention Of Ovarian Cancer By Administration Of A Vitamin D Compound

View page
US Patent:
7053074, May 30, 2006
Filed:
Jan 18, 2002
Appl. No.:
10/051662
Inventors:
Gustavo C. Rodriguez - Durham NC, US
Regina Salas Whitaker - Hillsborough NC, US
Assignee:
New Life Pharmaceuticals, Inc. - Chicago IL
International Classification:
A61K 31/59
A61K 31/56
US Classification:
514167, 514171, 514181
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Prevention Of Ovarian Cancer By Administration Of A Vitamin D Compound

View page
US Patent:
20040167106, Aug 26, 2004
Filed:
Feb 18, 2004
Appl. No.:
10/781173
Inventors:
Gustavo Rodriguez - Durham NC, US
Regina Whitaker - Hillsborough NC, US
International Classification:
A61K031/59
A61K031/573
A61K031/203
US Classification:
514/167000, 514/171000, 514/559000
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Prevention Of Ovarian Cancer By Administration Of A Vitamin D Compound

View page
US Patent:
20070010500, Jan 11, 2007
Filed:
May 26, 2006
Appl. No.:
11/441877
Inventors:
Gustavo Rodriguez - Durham NC, US
Regina Whitaker - Hillsborough NC, US
International Classification:
A61K 31/59
A61K 31/56
US Classification:
514167000, 514170000
Abstract:
The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.

Prevention Of Ovarian Cancer By Administration Of Agents That Induce Biologic Responses

View page
US Patent:
20070213543, Sep 13, 2007
Filed:
May 11, 2007
Appl. No.:
11/747571
Inventors:
Gustavo Rodriguez - Durham NC, US
International Classification:
C07D 311/02
US Classification:
549401000
Abstract:
The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of regulating TGF-β expression in the ovarian epithelium and/or capable of optimally altering expression of other surrogate biomarkers identified by microarray technology. HRT and OCP regimens comprising such compositions and methods are disclosed.
Control profile
Gustavo Menjivar Rodriguez from Clayton, NC, age ~44 Get Report